Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huiyu Ren
Institution:
Sanford Burnham Prebys Medical Discovery Institute
Observed institutions:
Sanford Burnham Prebys Medical Discovery Institute,
Peking University,
National Cancer Institute,
Center for Life Sciences
ORCID:
0009-0007-9696-2149
Observed ORCID:
0009-0007-9696-2149
OpenAlex ID:
A5088659568
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer
2020
·
Huiyu Ren
, Nicole A. Bakas
, et al.
·
Journal of Medicinal Chemistry
·
82
Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2)
2019
·
Apirat Chaikuad
, Sebastian E. Koschade
, et al.
·
Biochemical Journal
·
60
PDF
Acetylation of p53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway
2016
·
Tao Yun
, Kaiwen Yu
, et al.
·
Journal of Biological Chemistry
·
42
PDF
The autophagy initiating kinase ULK1 is required for pancreatic cancer cell growth and survival
2021
·
Sonja N. Brun
, Gencer Sancar
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
5
PDF
Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer
2026
·
Fabiana Izidro A. L. Layng
, Huiyu Ren
, et al.
·
ACS Chemical Biology
·
4
PDF
ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant Cancers
2025
·
Patrick M. Hagan
, Huiyu Ren
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 6873: Discovery and characterization of novel ULK1/2 inhibitors and their ability to degrade ATG13, inhibit autophagy, and treat lung cancer
2025
·
Patrick Martin Hagan
, Allison Limpert
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
193
H-index:
4
I10-index:
3
Year
Topic
Type